Tag Archives: treatment

Fat Cells in the Omentum Help Fuel Ovarian Cancer

A new study suggests that the “fatty apron” of cells found in the abdomen help ovarian cancer cells grow. This research could help provide direction for new targets in treatment. Read an article about the research here

Posted in News | Also tagged , | Leave a comment

Women with BRCA2 Mutation in Ovarian Tumors have Higher Surivival Rates

A recent study shows that women with ovarian cancer who have the BRCA2 mutation live longer than those with the BRCA1 mutation. Because the BRCA1 and BRCA2 mutations works slightly differently, they have a different effect on survival. The BRCA2 … Continue reading 

Posted in News | Also tagged , , , , , , | Leave a comment

Cost of Side Effects of Treatment Should Be Factored into Cost of Care

Often, the cost of care for a treatment does not include the cost of visitos to the provider or the cost of addressing side-effects. This calculation does not encompass the full cost of care for a new treatment regiment or … Continue reading 

Posted in News | Also tagged , | Leave a comment

JAAPA: When the Patient Asks – Can I be Screened for Ovarian Cancer

The JAAPA published a When the Patient Asks column on screening for ovarian cancer. WHO TO SCREEN High-risk women with a genetic mutation or strong family history should be screened. Routine transvaginal and pelvic ultrasonography with a CA-125 test may … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

Carbo/Paclitaxel v. Carbo/PLD as first line treatment for Ovarian Cancer

A recently study evaluated standard first line therapy – carboplatin plus paclitaxel – against carboplatin plus Doxil (PLD). This study of more than 800 women found that the use of Doxil was not superior to standard therapy, although the women … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

Interventions to prevent postoperative complications in women with ovarian cancer.

Women suspected of having ovarian cancer may have complications related to their surgeries. The most common complications, according to a recent studetn published in teh Clinical Journal of Oncology Nursing, were wound infection, fever, nausea and vomiting. The full article … Continue reading 

Posted in News | Also tagged , , , , | Leave a comment

GSH reduces toxicity of cisplatin in women with ovarian cancer

A study published in 1997 showed that glutathione (GSH), a supplement, can reduce the toxicities of treatment with cisplatin for women with ovarian cancer. Read the abstract here

Posted in News | Also tagged , | Leave a comment

FDA Clears ROMA Test (HE4+CA-125)

The FDA cleared the ROMA Algorithm, which uses the CA-125 and HE4 blood markers, to determine the likelihood that a pelvic mass is malignant. The test is a tool to help gynecologists appropriately refer women with masses that are likely to … Continue reading 

Posted in News | Also tagged , | Leave a comment

Personalizing CA-125 Levels for Ovarian Cancer Screening

Two new papers published in Cancer Prevention Research suggests that personalizing CA-125 levels related to ovarian cancer are helpful. The article suggests that the provide a two percent false positive rate are premenopausal women should have a cut-off point of 50 U/mL … Continue reading 

Posted in News | Also tagged | Leave a comment

The Annals of Extreme Surgery (NYT)

The New York Times ran an op-ed about the lack of evidence supporting heated chemotherapy (HIPEC). The article stated that while this new treatment gives patients hope, the data is not clear that it provides benefit. HIPEC is given to … Continue reading 

Posted in News | Also tagged , , , | Leave a comment

PAPR Inhibitors May Work Against More Ovarian Cancers

PAPR inhibitors, first used in trials for women with ovarian cancer who had a mutation in the BRCA1 or BRCA2 gene, are now being used in trials for women without these genetic mutations and showing some effect. In a recent … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Chemo Dosing Influences Drug Resistance

A mouse study showed that continuous treatment with docetaxel (Taxotere) showed greater anti-tumor effects than treating the mice once a week or once every three weeks. Additionally, treating less often led to genetic changes that may lead to drug resistance. … Continue reading 

Posted in News | Also tagged , , , , | 1 Comment